Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors

Human Gene Therapy

Volumn 10, Issue 7, 1999, Pages 1229-1238

  Brandenburger, Annick ^a   Coessens, Elise ^a,b   Bakkouri, Karim E L ^a   Velu, Thierry ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; VIRUS VECTOR;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENOME; HUMAN; HUMAN CELL; PARVOVIRUS; VIRUS RECOMBINANT; VIRUS TITRATION;

EID: 0033135296     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018210     Document Type: Article

References (50)

1. ALEMANY, R., DAI, Y., LOU, Y.C., SETHI, E., PROKOPENKO, E., JOSEPHS, S.F., and ZHANG, W.-W. (1997). Complementation of helper-dependent adenoviral vectors: Size effects and titer fluctuations. J. Virol. Methods 68, 147-159.
2. ASTELL, C.R., LIU, Q., HARRIS, C.E., BRUNSTEIN, J., JINDAL, H.K., and TAM, P. (1996). Minute virus of mice cis-acting sequences are required for genome replication and the role of the trans-acting viral protein, NS-1. Prog. Nucleic Acid Res. Mol. Biol. 55, 245-285.
3. AVALOSSE, B., DUPONT, F., SPEGELAERE, P., MINE, N., and BURNY, A. (1996). Method for concentrating and purifying recombinant autonomous parvovirus vectors designed for tumor-cell-targeted gene therapy. J. Virol. Methods 62, 179-183.
4. BALDAUF, A., WILLWAND, K., MUMTSIDI, E., NUESCH, J.P., and ROMMELAERE, J. (1997). Specific initiation of replication at the right-end telomere of the closed species of minute virus of mice replicative-form DNA. J. Virol. 71, 971-980.
5. BERNS, K.I. (1990). Parvovirus replication. Microbiol. Rev. 54, 316-329.
6. BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
7. BLOSS, T.A., and SUGDEN, B. (1994). Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J. Virol. 68, 8217-8222.
8. BOISSY, R., and ASTELL, C.R. (1985). An Escherichia coli recBC sbcB recF host permits the deletion-resistant propagation of plasmid clones containing the 5′-terminal palindrome of minute virus of mice. Gene 35, 179-185.
9. BRANDENBURGER, A., and RUSSELL, S.J. (1996). A novel packaging system for the generation of helper-tree oncolytic MVM vector stocks. Gene Ther. 3, 927-931.
10. BRANDENBURGER, A., LEGENDRE, D., AVALOSSE, B., and ROMMELAERE, J. (1990). NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVM(p). J. Virol. 174, 576-84.
11. BRUNSTEIN, J., and ASTELL, C.R. (1997). Analysis of the internal replication sequence indicates that there are three elements required for efficient replication of minute virus of mice minigenomes. J. Virol. 71, 9087-9095.
12. CAILLET-FAUQUET, P., PERROS, M., BRANDENBURGER, A., SPEGELAERE, P., and ROMMELAERE, J. (1990). Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J. 9, 2989-2995.
13. CHAPMAN, M.S., and ROSSMANN, M.G. (1993). Structure, sequence and function correlations among parvoviruses. Virology 194, 491-508.
14. CHAPMAN, M.S., and ROSSMANN, M.G. (1995). Single-stranded DNA-protein interactions in canine parvovirus. Structure 3, 151-162.
15. CHRISTENSEN, J., COTMORE, S.F., and TATTERSALL, P. (1997). A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication. J. Virol. 71, 1405-1416.
16. CORSINI, J., AFANASIEV, B., MAXWELL, I.H., and CARLSON, J.O. (1996). Autonomous parvovirus and densovirus gene vectors. Adv. Virus Res. 47, 303-351.
17. COSTELLO, E., SAHLI, R., HIRT, B., and TATTERSALL, P. (1995). The mismatched nucleotides in the 5′-terminal hairpin of minute virus of mice are required for efficient viral DNA replication. J. Virol. 69, 7489-7496.
18. COTMORE, S.F., and TATTERSALL, P. (1987). The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33, 91-169.
19. COTMORE, S.F., and TATTERSALL, P. (1994). An asymmetric nucleotide in the parvoviral 3′ hairpin directs segregation of a single active origin of DNA replication. EMBO J. 13, 4145-4152.
20. 2-3. J. Virol. 69, 1652-1660.
21. COTMORE. S.F., D'ABRAMO, A.M., CARBONELL, L.F., BRATTON, J., and TATTERSALL, P. (1997). The NS2 polypeptide of parvovirus MVM is required for capsid assembly in murine cells. Virology 231, 267-280.
22. DOERIG, C., HIRT, B., BEARD, P., and ANTONIETTI, J.P. (1988). Minute virus of mice non-structural protein NS-1 is necessary and sufficient for transactivation of the viral P39 promoter. J. Gen. Virol. 69, 2563-2573.
23. DOERIG, C., HIRT, B., ANTONIETTI, J.P., and BEARD, P. (1990). Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol. 64, 387-396.
24. DONG, J.-Y., FAN, P.-D., and FRIZZELL, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112.
25. DUPONT, F., TENENBAUM, L., DUO, L.-P., SEPGELEARE, P., ZEICHER, M., and ROMMELEARE, J. (1994). Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J. Virol. 68, 1397-1406.
26. DUPRESSOIR, T., LE CESNE, A., JANIN, J., SPIELMANN, M., LE CHEVALIER, T., SANCHO-GARNIER, H., PAOLETTI, C., STEHELIN, D., TURSZ, T., and ROMMELEARE, J. (1993). Abstracts of the 5th Parvovirus Workshop, Crystal River, Florida.
27. FAUST, E.A., and WARD, D.C. (1979). Incomplete genomes of the parvovirus minute virus of mice: Selective conservation of genome termini, including the origin for DNA replication. J. Virol. 32, 276-292.
28. GELINAS, C., and TEMIN, H.M. (1986). Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. U.S.A. 83, 9211-9215.
29. GORMAN, C. (1985). High efficiency gene transfer into mammalian cells. In DNA Cloning: A Practical Approach, Vol. 2. D.M. Glover, ed. (IRL Press, Oxford) pp. 143-165.
30. HERMONAT, P.L., QUIRK, J.G., BISHOP, B.M., and HAN, L. (1997). The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors. FEBS Lett. 407, 78-84.
31. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 363-369.
32. HUANG, A.S., and BALTIMORE, D. (1977). Defective interfering animal viruses. In Comprehensive Virology. Vol. 10. H. Fraenkel Conrat and R.R. Wagner, eds. (Plenum Press, New York) pp. 73-116.
33. KILHAM, L., and MARGOLIES, G. (1970). Pathogenicity of minute virus of mice (MVM) for rats, mice and hamsters. Proc. Soc. Exp. Biol. Med. 133, 1447-1452.
34. KIMSEY, P.B., ENGERS, H.D., HIRT, B., and JONGENEEL, C.V. (1986). Pathogenicity of fibroblast-and lymphocyte-specific variants of minute virus of mice. J. Virol. 59, 8-13.
35. KIRKWOOD, T.B., and BANGHAM, C.R. (1994). Cycles, chaos, and evolution in virus cultures: A model of defective interfering particles. Proc. Natl. Acad. Sci. U.S.A. 91, 8685-8689.
36. LAUGHLIN, C.A., MEYERS, M.W., RISIN, D.L., and CARTER, B.J. (1979). Defective-interfering particles of the human parvovirus adeno-associated virus. Virology 94, 162-174.
37. LEACH, D.R. (1996). Cloning and characterization of DNAs with palindromic sequences. Genet. Eng. (N.Y.) 18, 1-11.
38. LIU, Q., YOUNG, B., and ASTELL, C.R. (1994). In vitro resolution of the dimer bridge of the minute virus of mice (MVM) genome supports the modified rolling hairpin model for MVM replication. Virology 201, 251-262.
39. LOCKERT, D.H., and LYNCH, C.M. (1998). First Annual Meeting of the American Society of Gene Therapy, Seattle, Washington, May 27-31. [Poster 185]
40. MAXWELL, I.H., MAXWELL, F., RHODE, S.L., CORSINI, J., and CARLSON, J.O. (1993). Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum. Gene Ther. 4, 441-450.
41. MERCHLINSKY, M.J., TATTERSALL, P.J., LEARY, J.J., COTMORE, S.F., GARDINER, E.M., and WARD. D.C. (1983). Construction of an infective molecular clone of the autonomous parvovirus minute virus of mice. J. Virol. 47, 227-232.
42. RHODE, S.L. (1978). Defective interfering particles of parvovirus H-1. J. Virol. 27, 347-356.
43. ROMMELAERE, J., and CORNELIS, J.J. (1991). Antineoplastic activity of parvoviruses. J. Virol. Methods 33, 233-251.
44. RUSSELL, S.J. (1990). Lymphokine gene therapy for cancer. Immunol. Today 11, 196-200.
45. RUSSELL, S.J., BRANDENBURGER, A., FLEMMING, C.L., COLLINS, M.K.L., and ROMMELEARE, J. (1992). Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J. Virol. 66, 2821-2828.
46. SHAUGHNESSY, E., LU, D., CHATTERJEE, S., and WONG, K.K. (1996). Parvoviral vectors for the gene therapy of cancer. Semin. Oncol. 23, 159-171.
47. SHEIN, H.M., and ENDERS, J.F. (1962). Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissues. Proc. Soc. Exp. Biol. Med. 109, 495-500.
48. TAM, P., and ASTELL, C.R. (1993). Replication of minute virus of mice minigenomes: Novel replication elements required for MVM DNA replication. Virology 193, 812-814.
49. TOOLAN, H.W., SAUNDERS, E.L., SOUTHAM, C.M., MOORE, A.E., and LEVIN, A.C. (1965). H-1 virus viremia in the human. Proc. Soc. Exp. Biol. Med. 119, 711-715.
50. TSAO, J., CHAPMAN, M.S., AGBANDJE, M., KELLER, W., SMITH, K., WU, H., LUO, M., SMITH, T.J., ROSSMANN, M.G., COMPANS, R.W., and PARRlSH, C.R. (1991). The three-dimensional structure of canine parvovirus and its functional implications. Science 251, 1456-1464.